Search Results - "Min CK"

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors: Lee S Kim YJ Chung NG et al.

Source: Cancer (0008543X). 2/1/2009, Vol. 115 Issue 3, p561-570. 10p.

Insulin Signalling-Inducible IFITM1 Promotes Multiple Myeloma Progression and Bortezomib Resistance.

Authors: Lim JY Kim Y Park SS et al.

Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2026 Jun; Vol. 30 (11), pp. e71183.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE

Real-world clinical outcomes of tisagenlecleucel in relapsed or refractory diffuse large B-cell lymphoma: a single-center retrospective study.

Authors: Min GJ Kim TY Jeon YW et al.

Source: Frontiers in oncology [Front Oncol] 2026 Apr 24; Vol. 16, pp. 1823568. Date of Electronic Publication: 2026 Apr 24 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes.

Authors: Park SY Lee H Kwag D et al.

Source: Annals of hematology [Ann Hematol] 2026 Apr 21; Vol. 105 (5). Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process

Development and multinational validation of a multiple myeloma-specific comorbidity index using real-world cohorts: CAREMM-2108.

Authors: Choi S Byun JM Oh SE et al.

Corporate Authors: Choi S Byun JM Oh SE et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Mar 31; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Authors: Lee JY Choi S Jung S et al.

Corporate Authors: Lee JY Choi S Jung S et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 23; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 23.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Real-world outcomes of SLiM-only multiple myeloma: Korean Multicenter Retrospective analysis (KMM2401 study).

Authors: Yi JH Yoon DH Park SS et al.

Source: Annals of hematology [Ann Hematol] 2026 Feb 06; Vol. 105 (3), pp. 93. Date of Electronic Publication: 2026 Feb 06.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study.

Authors: Choi S Park SS Lee CH et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 30; Vol. 15 (1), pp. 185. Date of Electronic Publication: 2025 Oct 30.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

Authors: Kim JS Song Y Jen WY et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 06; Vol. 15 (1), pp. 155. Date of Electronic Publication: 2025 Oct 06.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation.

Authors: Lee JH Kwag D Min GJ et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 06; Vol. 15 (1), pp. 159. Date of Electronic Publication: 2025 Oct 06.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Plain language summary of publication of how long people with relapsed multiple myeloma lived after treatment in the IKEMA study: Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone.

Authors: Yong K Martin T Dimopoulos MA et al.

Source: Future oncology (London, England) [Future Oncol] 2026 Jun 27, pp. 1-13. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

Authors: Lee N Kim S Lee Y et al.

Source: Blood research [Blood Res] 2026 Jun 24; Vol. 61 (1). Date of Electronic Publication: 2026 Jun 24.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 101605247 Publication Model: Electronic Cited Medium: Print ISSN: 2287-979X (Print) Linking ISSN: 2287979X NLM ISO Abbreviation: Blood Res Subsets: PubMed not MEDLINE

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).

Authors: Lee JY Jung S Park SS et al.

Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Authors: Mina R Beksac M Rodríguez-Otero P et al.

Corporate Authors: Mina R Beksac M Rodríguez-Otero P et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Jun 13. Date of Electronic Publication: 2026 Jun 13.

Publication Type: Journal Article

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

Authors: Kim M Jang HC Ahn JS et al.

Source: Haematologica [Haematologica] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910).

Authors: Yi JH Yoon SE Lee JH et al.

Source: Cancer research and treatment [Cancer Res Treat] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal Function.

Authors: Chen X Hakim S Lien YTK et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 May 25. Date of Electronic Publication: 2026 May 25.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Relapse patterns focusing on central nervous system involvement after allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia.

Authors: Lee JH Ahn J Kwag D et al.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 May; Vol. 61 (5), pp. 529-536. Date of Electronic Publication: 2026 Mar 14.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Poor prognostic implication of CDKN2 deletion in adult patients with Philadelphia chromosome-positive ALL.

Authors: Park SY Kwag D Jung J et al.

Source: Blood cancer journal [Blood Cancer J] 2025 May 24; Vol. 15 (1), pp. 102. Date of Electronic Publication: 2025 May 24.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases.

Authors: Park SS Kim NY Lim JY et al.

Source: Annals of laboratory medicine [Ann Lab Med] 2025 May 01; Vol. 45 (3), pp. 279-290. Date of Electronic Publication: 2025 Feb 28.

Publication Type: Journal Article

Journal Info: Publisher: Korean Society for Laboratory Medicine Country of Publication: Korea (South) NLM ID: 101571172 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2234-3814 (Electronic) Linking ISSN: 22343806 NLM ISO Abbreviation: Ann Lab Med Subsets: MEDLINE